Last reviewed · How we verify
Enterobacter Osteomyelitis
Approved treatments
- Ramycin
Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins. - Tobi · Novartis
- Ciprofloxacine · Poitiers University Hospital
- Vantobra · Pfizer
- Nebcin · University Hospital, Lille
- Ceftriaxon · Centre Hospitalier Universitaire Vaudois
- Fortaz · Pai Holdings Pharm
Fortaz works by binding to penicillin-binding proteins on bacterial cell walls, preventing them from forming a strong cell wall and ultimately leading to bacterial cell death. - Fortaz · Pai Holdings Pharm
Bactericidal agent inhibiting bacterial cell wall synthesis with beta-lactamase resistance. - Noroxin
- Floxin
- Cipro · Bayer AG
- Rocephin · Generic (originally Roche)
- Ceftazidim · Tel-Aviv Sourasky Medical Center
- Ofloxacine · Assistance Publique - Hôpitaux de Paris
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Enterobacter Osteomyelitis patent landscape — cliff calendar, originator estates, attackable patents
- Enterobacter Osteomyelitis treatment landscape brief
- Enterobacter Osteomyelitis treatment updates RSS
Frequently asked questions about Enterobacter Osteomyelitis
What drugs treat Enterobacter Osteomyelitis?
Tracked treatments include Ramycin, Tobi, Ciprofloxacine, Vantobra, Nebcin, Ceftriaxon, Fortaz, Noroxin.
What is the treatment for Enterobacter Osteomyelitis?
Standard treatment for Enterobacter Osteomyelitis includes Ramycin, Tobi, Ciprofloxacine, Vantobra, Nebcin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Enterobacter Osteomyelitis patent cliff · Enterobacter Osteomyelitis CI report
- Treatment: Ramycin
- Treatment: Tobi · Novartis
- Treatment: Ciprofloxacine · Poitiers University Hospital
- Treatment: Vantobra · Pfizer
- Treatment: Nebcin · University Hospital, Lille
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing